Veradermics, Inc.
Clinical trials sponsored by Veradermics, Inc., explained in plain language.
-
New pill aims to fight genetic hair loss
Disease control OngoingThis study is testing an investigational oral tablet called VDPHL01 to see if it is safe and effective for treating genetic hair loss (pattern baldness) in men and women. About 70 participants will take the pill daily for one year while researchers track changes in hair count and…
Phase: PHASE2 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:41 UTC
-
New pill aims to fight hair loss in men
Disease control OngoingThis study is testing a new oral pill called VDPHL01 to see if it is safe and effective for treating male pattern baldness. It will involve about 480 men aged 18-65 with mild to moderate hair loss over a 13-month period. Researchers will compare the pill to a placebo to measure c…
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Pill for baldness? new drug trial seeks to regrow hair
Disease control OngoingThis study is testing whether an oral pill called VDPHL01 can help regrow hair in men with male pattern baldness. About 480 men will take either the pill or a placebo for 6 months, followed by an extension where everyone gets the active drug. The main goals are to see if the pill…
Phase: PHASE2, PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC